Business
CBD Unlimited Begins Product Launch Testing of Equine CBD Product
CBD Unlimited Begins Product Launch Testing of Equine CBD Product.
About this update from Endexx Corp.
[{"type":"text","content":"\n CBD Unlimited's TrailRMix Distributed for Field Study with Equine Professionals CAVE CREEK, AZ, March 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ CBD Unlimited, Inc. (EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, is pleased to announce that the first phase of product testing in field trials for its novel equine CBD product testing has officially commenced. This initial phase will examine and test the Company’s upcoming equine TrailRMix product line, which is expected to launch this year. CBD Unlimited has initiated a collaboration with veterinarians, horse caretakers, trainers and other equine experts to study the potential health benefits and applications of CBD for horses. This trial will be led by certified vets and researchers to ensure that through the testing process, the Company will determine the optimum dosage, potency and safety of the product throughout the trial’s duration. According to a study published by Market Study Report LLC., the equine supplement industry is projected to grow from 1 billion in 2018 to 1.25 billion by 2025. “This initial testing phase for our equine CBD product marks a key milestone for the Company,” commented Mr. Todd Davis, CEO and Chairman of CBD Unlimited. “We are excited to expand our animal product pipeline by providing safe and natural therapies for larger animals. We are thankful for the endless support from our development team and equine professionals who are taking the lead on this study.  Our product is formulated to optimize the delivery of CBD in to targeted areas of the body at a specific dosing range. The product is also designed to reduce irritation to the GI Tract of the horse while recovering from other conditions that cause discomfort for horses.” According to the Brightfield Group, the CBD pet market is projected to hit $1.7 Billion by 2023, and the Company strives to be at the forefront of the hemp-derived product market. CBD Unlimited has been devoted to formulating multi-spectrum hemp CBD products not only for people but for dogs and cats with its Phyto-Bites line. Following a successful roll-out of CBD pet products and showcasing at SuperZoo Expo 2019, the Company has seen an increased demand in hemp products for pets. The Company is prepared...